Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atkinson

Showing results (1471-1480 of 1,523) with videos related to

Pageof 153
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 21, 2025
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancerGottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markersParinya Samakkarnthai, Dominik Saul, Lei Zhang, et al.
Nature Communications|January 9, 2020
Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolismMegan M Weivoda, Chee Kian Chew, David G Monroe, et al.
Hepatology (Baltimore, Md.)|November 23, 2020
Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic DecompensationOmar Y Mousa, Brian D Juran, Bryan M McCauley, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
The New England Journal of Medicine|May 22, 2009
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsGideon M Hirschfield, Xiangdong Liu, Chun Xu, et al.
Journal of Medicinal Chemistry|July 7, 2021
Identification of a Series of <i>N</i>-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) ProteinsLee A Harrison, Stephen J Atkinson, Anna Bassil, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
Journal of Medicinal Chemistry|March 4, 2021
Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) InhibitorsHelen E Aylott, Stephen J Atkinson, Paul Bamborough, et al.
Plos One|November 12, 2014
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysisSarah J Atkinson, Natalie Z Cvijanovich, Neal J Thomas, et al.
Pageof 153

Showing results (1471-1480 of 1,523) with videos related to

Sort By:
Pageof 153
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 21, 2025
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancerGottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markersParinya Samakkarnthai, Dominik Saul, Lei Zhang, et al.
Nature Communications|January 9, 2020
Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolismMegan M Weivoda, Chee Kian Chew, David G Monroe, et al.
Hepatology (Baltimore, Md.)|November 23, 2020
Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic DecompensationOmar Y Mousa, Brian D Juran, Bryan M McCauley, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
The New England Journal of Medicine|May 22, 2009
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsGideon M Hirschfield, Xiangdong Liu, Chun Xu, et al.
Journal of Medicinal Chemistry|July 7, 2021
Identification of a Series of <i>N</i>-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) ProteinsLee A Harrison, Stephen J Atkinson, Anna Bassil, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
Journal of Medicinal Chemistry|March 4, 2021
Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) InhibitorsHelen E Aylott, Stephen J Atkinson, Paul Bamborough, et al.
Plos One|November 12, 2014
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysisSarah J Atkinson, Natalie Z Cvijanovich, Neal J Thomas, et al.
Pageof 153